Company / Operating Cash Flow per Share
AbbVie Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$10.73
FY2025
5-year range
$10.58 / $15.35
FY2021-FY2025
Trend
+1.5%
vs FY2024
Sector context
#9 of 210
Health Care
What the data says
Among 210 Health Care companies, AbbVie is in the top 4% for operating cash flow per share. Operating Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $10.73.
Based on SEC 10-K filings.
10.73 in FY2025 with a 5-year CAGR of -1.2%. Top quartile in the Health Care sector.
Declined from $12.85 to $10.73 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -10.4%
- 5-Year CAGR
- -1.2%
- 10-Year CAGR
- -
Sector benchmark
+102.5% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 1.5% year-over-year.
- Ranks #9 out of 210 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.73 | +1.5% |
| FY2024 | $10.58 | -17.7% |
| FY2023 | $12.85 | -13.8% |
| FY2022 | $14.91 | -2.9% |
| FY2021 | $15.35 | +34.9% |
| FY2020 | $11.38 | +36.9% |
| FY2019 | $8.31 | +1.0% |
| FY2018 | $8.23 | +35.3% |
| FY2017 | $6.08 | +39.1% |
| FY2016 | $4.37 | -6.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026